Thermo Fisher Scientific Inc.
TMO Healthcare Diagnostics & Research
Thermo Fisher Scientific Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.6 billion, up 3.91% from fiscal 2024.
- Revenue
- +9.13%
- EPS
- +8.64%
- Free cash flow
- +15.0%
- Total debt
- +22.8%
Quarter to September 2026, against a year earlier
Follow TMO
Alert me
Thermo Fisher Scientific Inc. (TMO) P/E ratio
As of 5 November 2026, Thermo Fisher Scientific Inc. (TMO) trades at a P/E ratio of 35.8×. Over the past ten years it has ranged from 22.0× (June 2021) to 47.4× (September 2020); the current reading is higher than 78% of that period. That is in line with the Diagnostics & Research industry median of 34.5× and above the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 32.6× | 3.92% |
| FY2024 | 31.4× | (10.51%) |
| FY2023 | 35.1× | 12.57% |
| FY2022 | 31.1× | (8.46%) |
| FY2021 | 34.0× | 17.54% |
| FY2020 | 28.9× | (17.66%) |
| FY2019 | 35.2× | 14.69% |
| FY2018 | 30.7× | (10.25%) |
| FY2017 | 34.2× | 21.96% |
| FY2016 | 28.0× | (2.27%) |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 35.5× | 32.02% |
| Jun 2026 | 26.9× | (0.19%) |
| Mar 2026 | 27.0× | (17.27%) |
| Dec 2025 | 32.6× | 16.58% |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| NTRA Natera, Inc. compare | n/m |
| IQV IQVIA Holdings Inc. compare | 31.8× |
| A Agilent Technologies, Inc. compare | 33.8× |
| ILMN Illumina, Inc. compare | 35.6× |
| TMO Thermo Fisher Scientific Inc. | 35.8× |
| DHR Danaher Corporation compare | 37.0× |
| MTD Mettler-Toledo International, Inc. compare | 37.6× |
| IDXX IDEXX Laboratories, Inc. compare | 44.8× |
| WAT Waters Corporation compare | 194× |
| Diagnostics & Research industry median | 34.5× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on TMO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement